Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06265688
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2024-02-12
Brief Title:
First In Human Study of CX-2051 in Advanced Solid Tumors
Sponsor:
CytomX Therapeutics
Organization:
CytomX Therapeutics
Organization Data
Organization:
CytomX Therapeutics
Class:
INDUSTRY
Study ID:
CTMX-2051-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CytomX Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None